FORCE For Knowledge

Coming – October 23

The Latest Advances In Gene Therapy

Date and Time

October 23

–

12:00 PM ET / 9:00 AM PT

Details will be provided upon RSVP approval

About this Event

Gene therapy stands at the forefront of medical innovation, offering the potential to not only treat but also cure a wide range of genetic disorders. With recent breakthroughs in delivery platforms, regulatory progress, and a surge of investment into the sector, the field is rapidly moving from scientific promise to clinical and commercial reality.

This webinar will explore the opportunities and challenges that lie ahead for gene therapy. The discussion will address the evolving therapeutic landscape, emerging technologies shaping the next wave of treatments, and the investment environment driving innovation and accessibility.

We are pleased to feature William Maughan, PhD, Managing Director of Equity Research at Clear Street, who brings a unique perspective at the intersection of science and markets. With deep expertise in life sciences and healthcare equities, Dr. Maughan provides critical insights into how investors evaluate gene therapy companies, the trends shaping capital flows, and what these dynamics mean for the future of patients, providers, and innovators alike.

Register now to join this FORCE For Knowledge event. Attendees will gain an informed understanding of gene therapy’s transformative potential, its investment outlook, and the pathways to translating groundbreaking science into real-world impact. This event is designed for those who are committed to shaping the next chapter of healthcare.

Sign Up Today

SHARE THIS EVENT

This presentation contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts and referenced statistics, contained in this presentation, including statements regarding future company strategy, operations, financial position, revenues, projected costs, plans and objectives of management, will be forward-looking statements.

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.